Mallinckrodt Recalls Amitiza Capsules Due to Labeling Mix-Up
Mallinckrodt Pharmaceuticals is recalling Amitiza (lubiprostone) capsules because 8 mcg and 24 mcg bottles were found with incorrect contents.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score. The hazard is a labeling mix-up involving dosage strength, which is a significant error but does not involve a high-risk pathogen or immediate structural defect.
Plain-English summary
Mallinckrodt Pharmaceuticals is recalling Amitiza (lubiprostone) capsules due to a labeling mix-up. The recall involves 89,808 bottles of Amitiza 8 mcg capsules, NDC 64764-080-60, Lot # 3229691-61, Exp 01/2022. The recall was initiated because 24 mcg capsules were found in a bottle labeled as 8 mcg.
Additionally, Amitiza 24 mcg capsules are being recalled because a sealed 60-count bottle was found to contain only 8 mcg capsules. The FDA classifies this incident as a labeling mix-up issue. The affected products were distributed nationwide in the United States.
Consumers should check their medication bottles for the specific lot number and expiration date listed above. If the product matches the recalled description, patients should contact their healthcare provider or pharmacist for guidance on how to proceed.
The recalled product
- Product
- AMITIZA (LUBIPROSTONE)
- Brand
- AMITIZA
- Manufacturer
- MALLINCKRODT PHARMACEUTICALS
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 89,808
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 3229691-61
- Exp 01/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by MALLINCKRODT PHARMACEUTICALS under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · AMITIZA
- ModerateAmitiza Capsules Recalled Due to Labeling Mix-Up Between Strengths
FDA (Drugs) · 2019-05-29
- LowTakeda Recalls Amitiza Capsules Due to Elevated Impurity Levels
FDA (Drugs) · 2018-11-21
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02